Outcomes of diffuse large b-cell lymphoma with MYC and/or BCL2 protein expression treated with intensive chemotherapy.

Authors

null

Amir Issa

The University of Texas MD Anderson Cancer Center, Houston, TX

Amir Issa , Vishwanath Sathyanarayanan , Michelle A. Fanale , Yasuhiro Oki , Fredrick B. Hagemeister Jr., Sattva Swarup Neelapu , Loretta J. Nastoupil , Nathan Hale Fowler , Francesco Turturro , Mansoor Noorani , Mohamed Amin Ahmed , Richard Eric Davis , Maria Alma Rodriguez , Michael Wang , Lei Feng , Ken H Young , Timothy McDonnell , Chelsea Camille Pinnix , Luis Fayad , Jason R. Westin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Citation

J Clin Oncol 34, 2016 (suppl; abstr 7563)

DOI

10.1200/JCO.2016.34.15_suppl.7563

Abstract #

7563

Poster Bd #

119

Abstract Disclosures

Similar Posters

First Author: Franck Morschhauser

First Author: Mohamad Barakat

First Author: Jason R. Westin

First Author: Kevin A. Hay